By Meg Tirrell, CNNPublished 6:30 AM EDT, Tue September 17, 2024 The new crop of GLP-1 weight loss drugs all come in the form of injections. New pill versions are in trials now. Illustration by Leah Abucayan/CNNJared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually...
September 11, 2024 by Diabetologia Credit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year’s Annual Meeting of the...
September 10, 2024 by Diabetologia Credit: Lukas from PexelsThe obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), and published simultaneously in the New England Journal of...
September 10, 2024 by Christopher Damman, The Conversation Credit: Pixabay/CC0 Public DomainIs the adage “calories in, calories out” true? The short answer is yes, but the full story is more nuanced. From the moment food touches your tongue to the time it leaves your body, your digestive system and gut microbiome work to extract its...
Medscape Medical News > Conference News > EASD 2024 Becky McCall September 12, 2024 MADRID — Amycretin, a dual pathway, oral weight loss drug, led to up to 13% body weight loss in participants with overweight or obesity according to phase 1, first-in-human study data presented at the European Association for the Study of Diabetes...
September 12, 2024 by Diabetologia Credit: Unsplash/CC0 Public DomainSemaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) held in Madrid,...
September 11, 2024 by Diabetologia Credit: Pixabay/CC0 Public DomainThe phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine (a long-acting insulin) for type 2 diabetes (T2D). Now new research examining a broad range of potential predictors of sustaining blood sugar control and weight...
September 3, 2024 by Perelman School of Medicine at the University of Pennsylvania Credit: Unsplash/CC0 Public DomainTaking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School...
By National Research Council of Science & TechnologyAugust 24, 2024 Dr. Ki-young Shin’s team at KERI is advancing research on neuromodulation technology, specifically transcranial random noise stimulation (tRNS), to treat metabolic syndrome by suppressing appetite through non-invasive electrical stimulation. Their clinical trials have shown promising results in reducing appetite and emotional eating, with further phases...
Written by Tracy Norfleet, MD, MBA, FACP, ABOM | Reviewed by Patricia Pinto-Garcia, MD, MPHPublished on June 10, 2024 Key takeaways: Vitamin B12 is an essential vitamin that your body needs to function properly. You can get enough vitamin B12 from either food or supplements, like vitamin B12 shots.People with a BMI over 30 can...
